Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-12-23Clinical Trial Update: Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases [Phase 2]
A Phase 2 clinical trial evaluating erlotinib with concurrent brain radiotherapy and secondary brain radiotherapy after recurrence in patien…
-
CLINICAL_TRIALS research · 2014-12-05Clinical Trial Update: Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System
This entry reports a clinical trial evaluating pemetrexed for metastatic non-small cell lung cancer in the Andalusian Public Health System. …
-
CLINICAL_TRIALS research · 2014-12-02Clinical Trial Update: Identification of EGFR-TKIs Sensitivity or Resistance Markers in NSCLC May Help in Optimal Patient Selection
This clinical trial update discusses efforts to identify biomarkers predicting sensitivity or resistance to EGFR-TKIs in non-small cell lung…
-
CLINICAL_TRIALS research · 2014-11-18Clinical Trial Update: Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR)
A completed retrospective study in non-small cell lung cancer focusing on EGFR-related aspects is reported in this clinical trial update.
-
CLINICAL_TRIALS research · 2014-11-11Clinical Trial Update: Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
The clinical trial update describes a trial comparing different surgical approaches for early-stage non-small cell lung cancer, including st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-11-05Clinical Trial Update: Value of Physical Capacity Tests in Lung Cancer
A completed clinical trial evaluating the value of physical capacity tests in patients with lung cancer (non-small cell and small cell).
-
CLINICAL_TRIALS research · 2014-10-22Clinical Trial Update: Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer [Phase 2]
A Phase 2 clinical trial investigating chemotherapy plus icotinib for EGFR mutation-positive non-small-cell lung cancer.
-
CLINICAL_TRIALS research · 2014-10-03Clinical Trial Update: Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy
A pilot study evaluates the use of the PET tracer 18F-FAZA to assess early functional response in patients with inoperable non-small cell lu…
-
CLINICAL_TRIALS research · 2014-09-26Clinical Trial Update: Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLC [Phase 2]
This clinical trial update describes a Phase 2 study evaluating an epidermal growth factor receptor tyrosine kinase inhibitor in patients wi…
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
This international study from The Netherlands Cancer Institute investigates using PET/CT in radiotherapy planning for non-small cell lung ca…
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]
This is a Phase 2 clinical trial evaluating chemotherapy tailored to BRCA1 and RRM1 mRNA status in advanced non-small cell lung cancer. The …
-
CLINICAL_TRIALS research · 2014-09-09Clinical Trial Update: Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System [Phase 2]
This clinical trial update describes a Phase II study evaluating risk-adapted stereotactic body radiotherapy for early non-small cell lung c…
-
CLINICAL_TRIALS research · 2014-08-27Clinical Trial Update: Paclitaxel-trastuzumab in EGFR-mutated NSCLC Patients [Phase 2]
A Phase 2 clinical trial at Amsterdam UMC evaluating the combination of paclitaxel and trastuzumab in patients with EGFR-mutated, HER2-expre…
-
CLINICAL_TRIALS research · 2014-08-22Clinical Trial Update: Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection [Phase 2]
This entry describes a Phase 2 clinical trial evaluating S-1 capsule as adjuvant therapy after complete resection for stage II to IIIA non-s…
-
CLINICAL_TRIALS research · 2014-08-22Clinical Trial Update: Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers
This clinical trial update reports the collection of blood samples from patients with non-small cell lung cancer and from healthy volunteers…
-
CLINICAL_TRIALS research · 2014-07-31Clinical Trial Update: Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer [Phase 2]
A Phase II clinical trial is investigating intermittent high-dose icotinib in combination with docetaxel for non-small cell lung cancer; tri…
-
CLINICAL_TRIALS research · 2014-07-30Clinical Trial Update: Genotyping of Non-small Cell Lung Cancer
This clinical trial update discusses genotyping of non-small cell lung cancer to identify associated gene abnormalities.
-
CLINICAL_TRIALS research · 2014-07-29Clinical Trial Update: Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer
A clinical trial update examining changes in lymphocyte subsets during chemotherapy in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2014-07-23Clinical Trial Update: Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients [NA]
Clinical trial update describes a study on the effectiveness and efficiency of physical exercise in cancer patients, with conditions includi…
-
CLINICAL_TRIALS research · 2014-07-21Clinical Trial Update: dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact. [NA]
A clinical trial update evaluating the time course of dMR during first-line treatment of non-small cell lung cancer and its potential progno…
-
CLINICAL_TRIALS research · 2014-07-18Clinical Trial Update: Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC [Phase 4]
A Phase 4 clinical trial from Betta Pharmaceuticals compares sequential and maintenance icotinib plus chemotherapy with icotinib maintenance…
-
CLINICAL_TRIALS research · 2014-05-23Clinical Trial Update: A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma [Phase 2]
A Phase II trial evaluates the efficacy of combining erlotinib (Tarceva) with silybin-phytosome (Siliphos) in patients with EGFR-mutant non-…
-
CLINICAL_TRIALS research · 2014-04-28Clinical Trial Update: Development of Circulating Tumour Cell Molecular Diagnostics Using a Novel Microfluidic Device
Progress update on developing a circulating tumor cell molecular diagnostic using a novel microfluidic device for non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2014-04-04Clinical Trial Update: Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed/ Platinum as First-line Therapy [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial compares maintenance therapy with gefitinib plus pemetrexed versus pemetrexed alone in stage IV non-small c…
-
CLINICAL_TRIALS research · 2014-03-31Clinical Trial Update: NSCLC Burden of Illness Study
This GlaxoSmithKline-sponsored NSCLC burden of illness study has completed, providing an update on the clinical trial assessing the burden o…